The Vincent Center for Reproductive Biology provides an environment that exposes clinicians to an integrated clinical and basic research program.
There are numerous projects ongoing within the Vincent Center for Reproductive Biology (VCRB) with emphasis on ovarian and uterine cancer, fetal/maternal interactions, menopause, infertility, and ovarian cell signaling.
Our goal is to provide each clinical research fellow with the opportunity to design, implement and critically review basic research projects on clinically important topics.
Opportunities are available for clinicians who are in an MGH fellowship. Contact any one of our faculty to find out more.
In the largest study of its kind to date, researchers have found the new mRNA COVID-19 vaccines to be highly effective in producing antibodies against the SARS-CoV-2 virus in pregnant and lactating women.
En el mayor estudio de este tipo realizado hasta la fecha, los investigadores han descubierto que las nuevas vacunas de ARNm contra el COVID-19 son muy eficaces para producir anticuerpos contra el virus del SARS-CoV-2 en mujeres embarazadas y lactantes.